[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Myelodysplastic syndromes (MDS)
  • Acute myeloid leukemia (AML)
  • Myeloproliferative neoplasms (MPN)

About

As a member of the Leukemia Research Program at the OSUCCC – James, my clinical and translational research focus is on novel therapeutics in myeloid diseases, with a special focus in disease progression from cytopenia and early-stage MDS to AML. I am the principal investigator for numerous investigator-initiated clinical trials based on laboratory science, including a promising study that looks at the novel combination of targeted therapies for myeloid malignancies. I am also the national lead and site investigator for several early-phase, industry-supported MDS and AML studies in both upfront and relapsed/refractory disease. My work has appeared in such peer-reviewed publications as Nature Medicine, Oncotarget, Blood Advances and Leukemia.

Location

The Ohio State University Comprehensive Cancer Center: 460 W 10th Ave, Columbus, OH 43210, USA

newsletter icon

Get the latest thought leadership on your Myelodysplastic Syndromes delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:

AbbVie
Bristol Myers Squibb

Follow Us

facebook instagram youtube